doi: 10.1007/s00401-009-0591-3
Without barriers such as digestion, the body absorbs 15-97% of the injected B12, making injections much more efficient at raising blood levels quickly even if the pill dose is higher
Stable gastric pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
Researchers reconstitute it for in vitro studies, examining fat burning, fat reduction, stubborn fat deposits, and peptide therapy interactions
BPC-157 has not received approval due to the absence of sufficient clinical studies confirming its health benefits in humans, according to the Food and Drug Administration (FDA)
The symptoms that matter most are the ones that suggest a more serious problem: severe abdominal pain, facial or throat swelling, blistering rash, major drops in urine output, or low blood sugar symptoms after a medication change